Remarkable response to chidamide plus rituximab in an elderly patient with recurrent, chemotherapy-refractory diffuse larger B-cell lymphoma carrying CREBBP mutation

被引：0
|
作者：
Zhang, Dongdong [1 ]
Han, Yidi [1 ]
Dong, Youhong [1 ]
机构：
[1] Hubei Univ Med, Xiangyang Peoples Hosp 1, Dept Oncol, Xiangyang 441000, Peoples R China
来源：
ANNALS OF HEMATOLOGY | 2023年 / 102卷 / 05期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1007/s00277-023-05183-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1265 / 1268
页数：4
相关论文
共 50 条
  • [41] Fulminant B hepatitis in a surface antigen and hepatitis B DNA-negative patient with diffuse large B-cell lymphoma after CHOP chemotherapy plus rituximab
    Yamagata, Michiko
    Murohisa, Toshimitsu
    Tsuchida, Kohei
    Okamoto, Yutaka
    Tsunoda, Saburo
    Nakamura, Masae
    Kusano, Koji
    Majima, Yuichi
    Kuniyoshi, Toru
    Iijima, Makoto
    Sugaya, Hitoshi
    Hiraishi, Hideyuki
    LEUKEMIA & LYMPHOMA, 2007, 48 (02) : 431 - 433
  • [42] Surgical resection combined with chop chemotherapy plus rituximab for a patient with advanced mesenteric diffuse large B cell lymphoma
    Yamaguchi, Tetsuya
    Takahashi, Hiroshi
    Kagawa, Ryuzaburou
    Takeda, Ryoji
    Sakata, Shingo
    Nishizaki, Daisuke
    Takamatsu, Teruyuki
    Iwasa, Yoko
    HEPATO-GASTROENTEROLOGY, 2008, 55 (84) : 891 - 894
  • [43] Efficacy and Safety of PD-1 Inhibitor Plus Rituximab in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Qin, Yan
    He, Xiaohui
    Yang, Sheng
    Liu, Peng
    Zhou, Shengyu
    Yang, Jianliang
    Gui, Lin
    Zhong, Qiaofeng
    Zhao, Fengyi
    Shi, Yuankai
    Jing, Hongmei
    Zhang, Shiyue
    Guo, Ruihan
    Shi, Yuankai
    BLOOD, 2021, 138
  • [44] Azacytidine plus rituximab-gemcitabine-oxaliplatin as salvage treatment in patients with relapsed/ refractory diffuse large B-cell lymphoma
    Meng Fanqiao
    Xiang Maoyuan
    Peng Cuicui
    Liu Yu
    Zeng Dongfeng
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S453 - S453
  • [45] Polatuzumab Vedotin in Combination with Bendamustine Plus Rituximab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Our Experience
    Darcin, Tahir
    Yigenoglu, Tugce Nur
    Sahin, Derya
    Bakirtas, Mehmet
    Basci, Semih
    Merdin, Alparslan
    Yildiz, Jale
    Ulu, Bahar Uncu
    Tetik, Aysegul
    Iskender, Dicle
    Cakar, Merih Kizil
    Dal, Mehmet Sinan
    Altuntas, Fevzi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S249 - S250
  • [46] Trial in Progress: Pomalidomide Plus Rituximab, Ifosfamide, Carboplatin, and Etoposide for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (PRIDE)
    Xu, Pengpeng
    Wang, Li
    Cheng, Shu
    Zhao, Wei Li
    BLOOD, 2021, 138
  • [47] CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
    Coiffier, B
    Lepage, E
    Brière, J
    Herbrecht, R
    Tilly, H
    Bouabdallah, R
    Morel, P
    Van den Neste, E
    Salles, G
    Gaulard, P
    Reyes, F
    Gisselbrecht, C
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (04): : 235 - 242
  • [48] Long-term efficacy of the combination of lenalidomide and rituximab in elderly relapsed/refractory diffuse large B-cell lymphoma patients
    Zinzani, Pier Luigi
    Pellegrini, Cinzia
    Derenzini, Enrico
    Argnani, Lisa
    Pileri, Stefano
    HEMATOLOGICAL ONCOLOGY, 2013, 31 (04) : 223 - 224
  • [49] Outcomes of Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Salvage Chemotherapy and Intention to Transplant in the Rituximab Era
    Vardhana, Santosha A.
    Moskowitz, Craig H.
    Sauter, Craig S.
    Matasar, Matthew J.
    Galasso, Natasha
    Woo, Kaitlin M.
    Zhang, Zhigang
    BLOOD, 2015, 126 (23)
  • [50] Outcomes of primary refractory diffuse large B-cell lymphoma (DLBCL) treated with salvage chemotherapy and intention to transplant in the rituximab era
    Vardhana, Santosha A.
    Sauter, Craig S.
    Matasar, Matthew J.
    Zelenetz, Andrew D.
    Galasso, Natasha
    Woo, Kaitlin M.
    Zhang, Zhigang
    Moskowitz, Craig H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 176 (04) : 591 - 599
12345